AntiShock
Noninvasive Monitoring Device for Assessing the Flow in Blood Vessels
Company Overview
Snapshot
Founded in August 2019 by Yokhai Dan (Yagdanov), Rami Shinnawi, and Dmitri Khalilov, AntiShock operates with 1–10 employees. The company has raised $850,000 across one funding round from two investors. In August 2019, AntiShock secured funding from the Israel Innovation Authority and MindUP.
Business overview
AntiShock develops a noninvasive continuous monitoring device designed to assess blood vessel flow. This technology aims to assist physicians in optimizing administered fluid dosage through a personalized approach. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Monitors, serving the healthcare industry with solutions for providers.
Log in to access full profile ›Company Intelligence Q&A
- What is AntiShock's primary focus?
- AntiShock focuses on developing a noninvasive continuous monitoring device to assess blood vessel flow, helping physicians optimize fluid dosage in a personalized manner.
- When was AntiShock founded and by whom?
- AntiShock was founded in August 2019 by Yokhai Dan (Yagdanov), Rami Shinnawi, and Dmitri Khalilov.
- What is the current status of AntiShock?
- AntiShock is currently non-active and ceased to operate in August 2024.
- Which sector does AntiShock operate in?
- AntiShock operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Monitors.
- What was AntiShock's last known funding event?
- In August 2019, AntiShock secured funding from the Israel Innovation Authority and MindUP.